H.R. 3443 · 116th Congress
To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.
- Stage
- In committee
- Sponsor
- Diana DeGette
- Introduced
- 2019-06-24
- Latest action
- 2019-07-24 · Sponsor introductory remarks on measure.
Subjects
Administrative law and regulatory procedures
Congressional oversight
Government studies and investigations
Health
User charges and fees
Inflation and prices
Child health
Department of Health and Human Services
Government information and archives
Marketing and advertising
Drug safety, medical device, and laboratory regulation
Administrative remedies
Judicial review and appeals
Cosmetics and personal care